Clinical Trials · NCT07693608
An Open-Label Tirzepatide Trial for Comorbid Obesity and Stimulant Use Disorder
- Phase
- Phase 2
- Recruitment status
- Enrolling By Invitation
- Sponsor
- University of Texas Southwestern Medical Center
- Enrollment
- 45
- Start date
- Aug 2026
- Locations
- 1 site, United States
- Primary endpoint
- Effect of tirzepatide on self-reported use of stimulants